Enter your terms above and click the 'Search' button.

Showing articles 0 to 13 of 13 Filter Applied: plasmapheresis (Click to remove) Immunotherapy of Multiple Sclerosis Ann Neurol 23:211-223, Weiner,H.L.&Hafler,D.A., 1988 Myasthenia Gravis NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016 Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders Neurol 78:1009-1015, Patwa,H.S.,et al, 2012 Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurol 76:294-300, Cortese,I.,et al, 2011 Evidence-based Guideline: Clinical Evaluation and Treatment of Transverse Myelitis Neurol 77:2128-2134, Scott, T.F.,et al, 2011 Clincopath Conference, Thrombotic Thrombocyclopenic Purpura in Patient with Lupus Nephritis NEJM 363:2352-2361, Case 37-2010, 2010 Practice Parameter:Immunotherapy for Guillain-Barre Syndrome, Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurol 61:736-740, Hughes,R.A.C.,et al, 2003 Disease Modifying Therapies in Multiple Sclerosis Neurol 58:169-178, Goodin,D.S.,et al, 2002 Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel NEJM 342:1773-1777,1824, Bennett,C.L.,et al, 2000 Thrombotic Thrombocytopenic Purpura:A Treatable Cause of Childhood Encephalopathy J Pediatr 130:313-316, Lawlor,E.R.,et al, 1997 Assessment of Plasmapheresis Report of the Therapeutics and Technology Assessment Subcommittee of the AAN, Neurol 47:840-8431996., , 1996 Progressive Encephalomyelitis with Rigidity Responsive to Plasmapheresis and Immunosuppression Ann Neurol 40:451-453, Fogan,L., 1996 Clinicopath Conf Thrombotic Thrombocytopenic Purpura, Case 30-1991, NEJM 325:265-273991., , 1991 Showing articles 0 to 13 of 13